1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Natulan: new trials by email Literature Review of Natulan trials Research Report on Natulan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Biospecimen Collection, Bleomycin Sulfate, Brentuximab Vedotin - Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 | Phase 3 | Recruiting | National Cancer Institute (NCI) | 1875 | 2023-05-11 | 2026-10-28 |
| Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma Bleomycin, Etoposide, Doxorubicin - Hodgkin Lymphoma | Phase 3 | Completed | Fondazione Michelangelo | 331 | 2000-03-01 | 2015-08-13 |
Hodgkin Disease (1)
Fondazione Michelangelo (1) · National Cancer Institute (NCI) (1)
Canada (1) · Italy (1) · Puerto Rico (1) · United States (1)
Alessandro M Gianni, MD (1) · Kara M Kelly (1)
U10CA180886 (1)